DME is a diabetes complication that threatens your the clarity of your vision. But managing blood sugar, blood pressure, and ...

Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.

Diabetes is a chronic condition that makes it difficult for your body to regulate blood sugar. When left unmanaged, both type 1 and type 2 diabetes can lead to serious health complications throughout ...

You may think diabetic macular edema (DME) affects older people only. But the truth is, the eye condition can develop in anyone with type 1 or type 2 diabetes. DME is more common in people with type 2 ...

Left unmanaged, this diabetes-related complication can lead to vision changes. Implementing the right strategies can help you protect your eyesight. When high blood sugar levels related to diabetes ...

Treatment-naïve BRVO eyes showed logMAR BCVA improvement (0.64 to 0.41) alongside CRT reduction (527 µm to 285 µm) over short-term follow-up with SB15. Central RVO eyes improved from logMAR 1.29 to 0.

Researchers also suggest potential new genetic associations with macular edema, which warrant further research. A study published in Scientific Reports confirmed previously identified retinal ...

Vabysmo now covered across all three approved indications in the province, providing patients with a comprehensively funded option for their needs "This expansion in coverage for people with RVO in ...